DR51.3 DataRelease

Release Date: June 2024
New Studies: 1
Updated Studies: 0

New Studies

SDY2491: SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023

Status:

New

Description:

Here, the authors describe results of a cross-sectional hospital-based study of anti-spike seroprevalence in New York City (NYC) from February 2020 to July 2022, and a follow-up period from August 2023 to October 2023.

Program/Contract:

Program	Contract
CIVICs Collaborative Influenza Vaccine Innovation Centers	Sinai-Emory Multi-Institutional CIVIC (SEM CIVIC)

DOI:

10.21430/M3X08KNYJ3

Subjects:

55092

Study PI, contact:

Name	Organization	Site
Juan Manuel Carreno	Icahn School of Medicine at Mount Sinai	ISMM_SEM-CIVIC Sinai-Emory Multi-Institutional CIVIC (SEM-CIVIC)
Florian Krammer	Icahn School of Medicine at Mount Sinai	ISMM_SEM-CIVIC Sinai-Emory Multi-Institutional CIVIC (SEM-CIVIC)

Publications:

None. None None None. doi: None [Pubmed: Not Applicable]

Resources:

Not Applicable Not Applicable]

Assays:

Assay Type	Number of Exp. Samples
ELISA	0

Clinical Assessments:

None